BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,764 | +0.6% | 33,300 | 0.0% | 0.00% | – |
| Q2 2023 | $234,432 | +25.5% | 33,300 | +48.7% | 0.00% | – |
| Q1 2023 | $186,816 | -64.9% | 22,400 | -51.6% | 0.00% | -100.0% |
| Q4 2022 | $531,524 | -29.3% | 46,300 | -22.4% | 0.00% | -50.0% |
| Q3 2022 | $752,000 | -84.1% | 59,700 | -86.6% | 0.00% | -50.0% |
| Q2 2022 | $4,715,000 | -5.0% | 445,675 | +46.0% | 0.00% | 0.0% |
| Q1 2022 | $4,962,000 | +36.2% | 305,179 | +16.0% | 0.00% | +33.3% |
| Q4 2021 | $3,642,000 | +76.4% | 263,115 | +83.1% | 0.00% | +50.0% |
| Q3 2021 | $2,065,000 | +3076.9% | 143,708 | +953.8% | 0.00% | – |
| Q2 2020 | $65,000 | -79.0% | 13,637 | -87.4% | 0.00% | – |
| Q3 2019 | $309,000 | -69.3% | 107,890 | -59.3% | 0.00% | -100.0% |
| Q2 2019 | $1,005,000 | -63.1% | 265,144 | -20.8% | 0.00% | -66.7% |
| Q1 2019 | $2,725,000 | +25.3% | 334,728 | +24.2% | 0.00% | +50.0% |
| Q4 2018 | $2,174,000 | +2.4% | 269,403 | -3.2% | 0.00% | 0.0% |
| Q3 2018 | $2,124,000 | +60.9% | 278,418 | +20.8% | 0.00% | +100.0% |
| Q2 2018 | $1,320,000 | +19.5% | 230,413 | -0.6% | 0.00% | 0.0% |
| Q1 2018 | $1,105,000 | +36.4% | 231,761 | +40.5% | 0.00% | 0.0% |
| Q4 2017 | $810,000 | -3.0% | 164,978 | +3.5% | 0.00% | 0.0% |
| Q3 2017 | $835,000 | +27.7% | 159,364 | +35.5% | 0.00% | 0.0% |
| Q2 2017 | $654,000 | -35.1% | 117,637 | -2.0% | 0.00% | 0.0% |
| Q1 2017 | $1,008,000 | +308.1% | 119,978 | +453.7% | 0.00% | – |
| Q3 2015 | $247,000 | – | 21,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $62,538,000 | 25.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,733 | $27,979,000 | 5.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 57,000 | $19,282,000 | 4.35% |
| MPM BioImpact LLC | 639,089 | $10,392,000 | 2.79% |
| Parkman Healthcare Partners LLC | 476,978 | $7,756,000 | 2.27% |
| Sarissa Capital Management LP | 1,390,790 | $22,614,000 | 2.14% |
| Ghost Tree Capital, LLC | 350,000 | $5,691,000 | 1.24% |
| Lisanti Capital Growth, LLC | 662,644 | $10,775,000 | 1.21% |
| Baker Brothers Advisors | 12,710,818 | $206,678,000 | 1.19% |
| Tamarack Advisers, LP | 125,000 | $2,033,000 | 0.96% |